Free Trial

Vestcor Inc Invests $3.30 Million in National Health Investors, Inc. (NYSE:NHI)

National Health Investors logo with Finance background

Vestcor Inc acquired a new position in National Health Investors, Inc. (NYSE:NHI - Free Report) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 39,225 shares of the real estate investment trust's stock, valued at approximately $3,297,000. Vestcor Inc owned 0.09% of National Health Investors as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC acquired a new stake in shares of National Health Investors in the second quarter worth $28,000. Thrivent Financial for Lutherans acquired a new stake in National Health Investors during the 3rd quarter worth about $2,426,000. Acadian Asset Management LLC purchased a new position in National Health Investors during the 2nd quarter valued at about $457,000. LSV Asset Management increased its holdings in shares of National Health Investors by 3.7% in the 2nd quarter. LSV Asset Management now owns 131,400 shares of the real estate investment trust's stock valued at $8,900,000 after purchasing an additional 4,700 shares during the period. Finally, ClariVest Asset Management LLC purchased a new stake in shares of National Health Investors in the second quarter worth approximately $2,465,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Stock Down 1.8 %

National Health Investors stock traded down $1.36 during mid-day trading on Wednesday, hitting $72.94. 265,580 shares of the company's stock were exchanged, compared to its average volume of 198,983. National Health Investors, Inc. has a 1-year low of $51.59 and a 1-year high of $86.13. The stock has a 50 day moving average of $77.37 and a two-hundred day moving average of $75.34. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a market cap of $3.31 billion, a P/E ratio of 25.07, a P/E/G ratio of 5.05 and a beta of 1.04.

National Health Investors (NYSE:NHI - Get Free Report) last released its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company had revenue of $63.32 million for the quarter, compared to the consensus estimate of $67.93 million. During the same quarter last year, the company posted $1.08 EPS. The business's revenue was up 1.7% compared to the same quarter last year. As a group, analysts anticipate that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a dividend yield of 4.94%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors's dividend payout ratio is 123.71%.

Wall Street Analysts Forecast Growth

NHI has been the topic of several research reports. Truist Financial upped their price objective on shares of National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research note on Friday, August 30th. Wells Fargo & Company lowered National Health Investors from an "overweight" rating to an "equal weight" rating and increased their price objective for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America began coverage on National Health Investors in a research report on Tuesday, September 24th. They set a "buy" rating and a $92.00 price objective for the company. Finally, StockNews.com lowered National Health Investors from a "buy" rating to a "hold" rating in a research report on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $76.33.

View Our Latest Analysis on National Health Investors

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Stories

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Should you invest $1,000 in National Health Investors right now?

Before you consider National Health Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.

While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?

AVGO is up 30% since earnings: could Broadcom be the next member of the Magnificent Seven? Can it sustain this momentum or is a pullback on the horizon?

Related Videos

Why Meta Is Still a Top Stock Pick for 2025
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines